I agree that this site is using cookies. You can find further informations here.
X
Taskar, Kunal
41  results:
Search for persons X
?
1

Considerations for Industry—Preparing for the FDA Model‐Inf..:

Galluppi, Gerald R. ; Ahamadi, Malidi ; Bhattacharya, Souvik...
Clinical Pharmacology & Therapeutics.  , 2024
Link: https://doi.org/10.1002/..
 
?
2

No dose adjustment of metformin or substrates of organic ca..:

Nguyen, Dung ; Miao, Xiusheng ; Taskar, Kunal...
Pharmacology Research & Perspectives.  12 (2024)  4 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
3

Effect of Cyclosporin A and Impact of Dose Staggering on OA..:

Mochizuki, Tatsuki ; Zamek‐Gliszczynski, Maciej J. ; Yoshida, Kenta...
Clinical Pharmacology & Therapeutics.  111 (2022)  6 - p. 1315-1323 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Physiologically‐based pharmacokinetic model‐based translati..:

Mochizuki, Tatsuki ; Aoki, Yasunori ; Yoshikado, Takashi...
Clinical and Translational Science.  15 (2022)  6 - p. 1519-1531 , 2022
Link: https://doi.org/10.1111/..
 
?
5

Clinical Implications of Altered Drug Transporter Abundance..:

Chu, Xiaoyan ; Prasad, Bhagwat ; Neuhoff, Sibylle...
Clinical Pharmacology & Therapeutics.  112 (2022)  3 - p. 501-526 , 2022
Link: https://doi.org/10.1002/..
 
?
6

Current Practices, Gap Analysis, and Proposed Workflows for..:

Hariparsad, Niresh ; Ramsden, Diane ; Taskar, Kunal...
Clinical Pharmacology & Therapeutics.  112 (2021)  4 - p. 770-781 , 2021
Link: https://doi.org/10.1002/..
 
?
7

Vinorelbine Delivery and Efficacy in the MDA-MB-231BR Precl..:

Samala, Ramakrishna ; Thorsheim, Helen R. ; Goda, Satyanarayana...
Pharmaceutical Research.  33 (2016)  12 - p. 2904-2919 , 2016
Link: https://doi.org/10.1007/..
 
?
8

Uptake of ANG1005, A Novel Paclitaxel Derivative, Through t..:

Thomas, Fancy C. ; Taskar, Kunal ; Rudraraju, Vinay...
Pharmaceutical Research.  26 (2009)  11 - p. 2486-2494 , 2009
Link: https://doi.org/10.1007/..
 
?
9

Development of a physiologically based pharmacokinetic mode..:

Salem, Farzaneh ; Nguyen, Dung ; Bush, Mark...
CPT: Pharmacometrics & Systems Pharmacology.  , 2024
Link: https://doi.org/10.1002/..
 
?
10

Physiologically‐based pharmacokinetic modeling of prominent..:

Lewis, Gareth J. ; Ahire, Deepak ; Taskar, Kunal S.
CPT: Pharmacometrics & Systems Pharmacology.  13 (2024)  4 - p. 563-575 , 2024
Link: https://doi.org/10.1002/..
 
?
11

Physiologically based pharmacokinetic modeling for developm..:

Salem, Farzaneh ; Nimavardi, Ali ; Mudunuru, Jennypher...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  6 - p. 808-820 , 2023
Link: https://doi.org/10.1002/..
 
?
12

Robust physiologically based pharmacokinetic model of rifam..:

Asaumi, Ryuta ; Nunoya, Ken‐ichi ; Yamaura, Yoshiyuki..
CPT: Pharmacometrics & Systems Pharmacology.  11 (2022)  7 - p. 919-933 , 2022
Link: https://doi.org/10.1002/..
 
?
13

Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibitio..:

Taskar, Kunal S. ; Yang, Xinning ; Neuhoff, Sibylle...
Clinical Pharmacology & Therapeutics.  112 (2022)  3 - p. 573-592 , 2022
Link: https://doi.org/10.1002/..
 
?
14

When special populations intersect with drug–drug interacti..:

Sychterz, Caroline ; Galetin, Aleksandra ; Taskar, Kunal S.
Biopharmaceutics & Drug Disposition.  42 (2021)  4 - p. 160-177 , 2021
Link: https://doi.org/10.1002/..
 
?
15

Industrial Perspective on the Benefits Realized From the FD..:

Galluppi, Gerald R. ; Brar, Satjit ; Caro, Luzelena...
Clinical Pharmacology & Therapeutics.  110 (2021)  5 - p. 1172-1175 , 2021
Link: https://doi.org/10.1002/..
 
1-15